Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, Gianenrico Senna, Giovanni Passalacqua, Antonio Spanevello, Stefano Aliberti, Diego Bagnasco, Marco Bonavia, Matteo Bonini, Luisa Brussino, Caterina Bucca, Maria F. Caiaffa, Cecilia Calabrese, Gianna Camiciottoli, Marco Caminati, Giovanna E. Carpagnano, Cristiano Caruso, Stefano Centanni, Maria E. Conte, Angelo G. Corsico, Lorenzo Cosmi, Maria T. Costantino, Nunzio Crimi, Simona D’Alò, Maria D'Amato, Stefano Del Giacco, Alessandro Farsi, Elisabetta Favero, Maria P. Foschino Barbaro, Gabriella Guarnieri, Giuseppe Guida, Manuela Latorre, Salvatore Lo Cicero, Carlo Lombardi, Luigi Macchia, Francesco Mazza, Francesco Menzella, Manlio Milanese, Marcello Montagni, Paolo Montuschi, Eleonora Nucera, Roberta Parente, Vincenzo Patella, Girolamo Pelaia, Laura Pini, Francesca Puggioni, Luisa Ricciardi, Fabio L.M. Ricciardolo, Luca Richeldi, Erminia Ridolo, Giovanni Rolla, Pierachille Santus, Nicola Scichilone, Giuseppe Spadaro, Andrea Vianello, Vittorio Viviano, Mona R. Yacoub, Maria C. Zappa, Enrico Heffler
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	Elsevier 2020-10-01
श्रृंखला:	World Allergy Organization Journal
विषय:	Severe asthma Biologics Oral corticosteroids Real-life Registr
ऑनलाइन पहुंच:	http://www.sciencedirect.com/science/article/pii/S1939455120303677

समान संसाधन

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
द्वारा: Claudia Crimi, और अन्य
प्रकाशित: (2023-11-01)

Economic impact of a more extensive use of FENO testing on the Italian population with asthma
द्वारा: Carla Rognoni, और अन्य
प्रकाशित: (2023-06-01)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
द्वारा: Paolo Solidoro, और अन्य
प्रकाशित: (2022-01-01)

Critical evaluation of asthma biomarkers in clinical practice
द्वारा: Giuseppe Guida, और अन्य
प्रकाशित: (2022-10-01)

Nasal polyps impact in severe asthma patients: evidences from the SANI
द्वारा: Giorgio Walter Canonica, और अन्य
प्रकाशित: (2020-08-01)

Asthma severity: the patient’s point of view
द्वारा: Gabriella Guarnieri, और अन्य
प्रकाशित: (2024-12-01)

Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
द्वारा: Giovanna Elisiana Carpagnano, और अन्य
प्रकाशित: (2023-10-01)

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
द्वारा: Marco Caminati, MD, और अन्य
प्रकाशित: (2024-08-01)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
द्वारा: Diego Bagnasco, और अन्य
प्रकाशित: (2023-08-01)

Phenotype overlap in the natural history of asthma
द्वारा: Fabio L.M. Ricciardolo, और अन्य
प्रकाशित: (2023-05-01)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
द्वारा: Paolo Solidoro, और अन्य
प्रकाशित: (2019-04-01)

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
द्वारा: Alessandra Vultaggio, और अन्य
प्रकाशित: (2023-05-01)

Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies
द्वारा: Giorgio Walter Canonica, और अन्य
प्रकाशित: (2021-09-01)

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
द्वारा: Giorgio Walter Canonica, MD, और अन्य
प्रकाशित: (2025-01-01)

Tezepelumab: patient selection and place in therapy in severe asthma
द्वारा: Francesco Menzella, और अन्य
प्रकाशित: (2024-04-01)

Treatment strategies for asthma: reshaping the concept of asthma management
द्वारा: Alberto Papi, और अन्य
प्रकाशित: (2020-08-01)

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
द्वारा: Maria D'Amato, और अन्य
प्रकाशित: (2022-05-01)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
द्वारा: Giulia Scioscia, और अन्य
प्रकाशित: (2020-03-01)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
द्वारा: Corrado Pelaia, और अन्य
प्रकाशित: (2023-03-01)

Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
द्वारा: Diego Bagnasco, और अन्य
प्रकाशित: (2020-08-01)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
द्वारा: Dejan Radovanovic, और अन्य
प्रकाशित: (2017-05-01)

Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma
द्वारा: Francesca Bertolini, और अन्य
प्रकाशित: (2025-02-01)

Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
द्वारा: Erminia Ridolo, और अन्य
प्रकाशित: (2020-10-01)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
द्वारा: Dejan Radovanovic, और अन्य
प्रकाशित: (2017-06-01)

Is it severe asthma or asthma with severe comorbidities?
द्वारा: Brussino L, और अन्य
प्रकाशित: (2017-11-01)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
द्वारा: Giovanna Elisiana Carpagnano, और अन्य
प्रकाशित: (2021-03-01)

Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
द्वारा: Carlo Lombardi, और अन्य
प्रकाशित: (2024-11-01)

The extracellular matrix of the lung and airway responsiveness in asthma
द्वारा: F.G. Salerno, और अन्य
प्रकाशित: (2016-01-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
द्वारा: Carlo Lombardi, और अन्य
प्रकाशित: (2024-07-01)

Alexithymia and asthma: a systematic review
द्वारा: Orlando Silvestro, और अन्य
प्रकाशित: (2023-08-01)

Interleukin-5 in the Pathophysiology of Severe Asthma
द्वारा: Corrado Pelaia, और अन्य
प्रकाशित: (2019-12-01)

Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
द्वारा: Carpagnano GE, और अन्य
प्रकाशित: (2019-03-01)

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
द्वारा: Giorgio Walter Canonica, और अन्य
प्रकाशित: (2018-11-01)

Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis
द्वारा: Filippo Rumi, और अन्य
प्रकाशित: (2022-04-01)

Comparison between clinical trials and real-world evidence studies on biologics for severe asthma
द्वारा: Francesco Menzella, और अन्य
प्रकाशित: (2022-11-01)

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
द्वारा: Cristiano Caruso, और अन्य
प्रकाशित: (2022-09-01)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
द्वारा: Andrea Portacci, और अन्य
प्रकाशित: (2023-10-01)

Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab
द्वारा: Andrea Giovanni Ledda, और अन्य
प्रकाशित: (2023-09-01)

Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma—A Multidisciplinary Monocentric Real-Life Study
द्वारा: Gian Luca Fadda, और अन्य
प्रकाशित: (2025-02-01)

Induced sputum is a reproducible method to assess airway inflammation in asthma
द्वारा: Elena Bacci, और अन्य
प्रकाशित: (2002-01-01)